Guilin Sanjin Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guilin Sanjin Pharmaceutical Co Ltd with three other
companies in this sector in CHINA :
Lionco Pharmaceutical Group Co Ltd
sales of 1.64 billion Chinese Renmimbi [US$234.85 million]
of which 42%
Tianjin Lisheng Pharmaceutical Company Limited
(1.62 billion Chinese Renmimbi [US$232.02 million]
of which 80%
was Tablet), and
Yipinhong Pharmaceutical Co Ltd
(1.64 billion Chinese Renmimbi [US$235.20 million]
of which 78%
was Pharmaceutical Manufacturing).
Guilin Sanjin Pharmaceutical Co Ltd reported sales of 1.64 billion Chinese Renmimbi (US$235.62 million)
December of 2019.
increase of 3.5%
versus 2018, when the company's sales were 1.58 billion Chinese Renmimbi.
Sales of Other Operation saw an increase
that was more than double the company's growth rate: sales were up
18.9% in 2019, from
98.65 million Chinese Renmimbi to 117.26 million Chinese Renmimbi.
Guilin Sanjin Pharmaceutical Co Ltd also saw significant increases in sales in
Commodity Circulation (up 15.1% to 38.69 million Chinese Renmimbi)
Other Business (up 6.3% to 1.60 million Chinese Renmimbi)
Not all segments of Guilin Sanjin Pharmaceutical Co Ltd experienced an increase in sales in 2019:
sales of Others fell 7.1% to 6.86 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).